Tarsus to Participate in Upcoming Investor Conference
Rhea-AI Summary
Tarsus (NASDAQ:TARS) said management will participate in a fireside chat at BTIG 5th Annual Ophthalmology Day on Monday, December 1, 2025 at 10:45 a.m. PT / 1:45 p.m. ET.
A live webcast will be available on the events section of the Tarsus website, and a replay will be posted within 48 hours and archived for a limited time.
Positive
- None.
Negative
- None.
IRVINE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management will participate in a fireside chat at the BTIG 5th Annual Ophthalmology Day on Monday, December 1st, at 10:45 a.m. PT / 1:45 p.m. ET.
A live webcast and additional information can be accessed on the events section of the Tarsus website. The replay will be available on the Tarsus website within 48 hours and will be archived for a limited time.
About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care, dermatology, and infectious disease prevention. XDEMVY® (lotilaner ophthalmic solution)
Media Contact:
Adrienne Kemp
Sr. Director, Corporate Communications
(949) 922-0801
AKemp@tarsusrx.com
Investor Contact:
David Nakasone
Head of Investor Relations
(949) 620-3223
DNakasone@tarsusrx.com